340B Report (February 24, 2024) - The drugmaker vendor 340B ESP’s recent requests for additional claims data from some 340B hospitals has raised concerns from 340B providers that the vendor is going beyond the scope of what it is legally...
340B Report (February 24, 2024) – The drugmaker vendor 340B ESP’s recent requests for additional claims data from some 340B hospitals has raised concerns from 340B providers that the vendor is going beyond the scope of what it is legally permissible to collect.
An email obtained by 340B Report from 340B ESP to a 340B hospital asked the provider to help determine “how best to collect claims data for 340B utilization that occurs within an outpatient setting – as opposed to claims related to retail dispenses…
More Articles
Financial clarity, when tied directly to program activity, gives leadership teams a more reliable foundation for decision-making and long-term planning.
Before adopting automation and AI tools, leaders should have a clear understanding of the business challenge, the desired outcome, and how technology can support that...
When DMF certification becomes a necessity, understanding how controls, documentation, and attestation come together is key to meeting NTIS requirements.
